ARTA
LPCN icon

A.R.T. Advisors’s Lipocine LPCN Stock Holding History

A.R.T. Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-699
Closed -$16K – 1516
2018
Q3 		$16K Sell
699
-440
-39% -$10.8K ﹤0.01% 1354
2018
Q2 		$25K Buy
+1,139
New +$27.2K ﹤0.01% 1355
2017
Q4 		– Sell
-963
Closed -$64K – 1542
2017
Q3 		$64K Buy
+963
New +$69.6K ﹤0.01% 1243
2017
Q2 		– Sell
-1,121
Closed -$74K – 1580
2017
Q1 		$74K Buy
+1,121
New +$72.7K ﹤0.01% 1305
2015
Q4 		– Sell
-5,155
Closed -$1.04M – 1608
2015
Q3 		$1.04M Buy
5,155
+4,506
+694% +$1.04M 0.04% 617
2015
Q2 		$94K Buy
+649
New +$80.5K ﹤0.01% 1373
2015
Q1 		– Sell
-799
Closed -$71K – 1568
2014
Q4 		$71K Buy
+799
New +$67.5K ﹤0.01% 1325

Other funds holding LPCN

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

A.R.T. Advisors's LPCN Position: Q4 2018 in Review

A.R.T. Advisors sold out of Lipocine (LPCN) in Q4 2018, closing a stake of 699 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in LPCN in Q4 2014 and held it in 7 quarters. The position peaked at $1.04M in Q3 2015. 24 funds tracked by Wall St. Rank hold LPCN as of Q4 2018.

  • A.R.T. Advisors reported no remaining Lipocine position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 699 Lipocine shares in Q4 2018, an estimated $16K.
  • A.R.T. Advisors first reported a position in Lipocine in Q4 2014 and held it in 7 quarters.
  • A.R.T. Advisors's Lipocine position peaked at $1.04M in Q3 2015.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.